NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Revolution Medicines Inc (NASDAQ: RVMD)

 
RVMD Technical Analysis
5
As on 9th Jun 2023 RVMD STOCK Price closed @ 25.54 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 21.15 & Strong Buy for SHORT-TERM with Stoploss of 22.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RVMDSTOCK Price

Open 24.81 Change Price %
High 25.75 1 Day 0.70 2.82
Low 24.61 1 Week -0.07 -0.27
Close 25.54 1 Month 2.48 10.75
Volume 446500 1 Year 1.01 4.12
52 Week High 30.09 | 52 Week Low 14.54
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
RVMD
Daily Charts
RVMD
Intraday Charts
Whats New @
Bazaartrend
RVMD
Free Analysis
 
RVMD Important Levels Intraday
RESISTANCE27.74
RESISTANCE27.03
RESISTANCE26.60
RESISTANCE26.16
SUPPORT24.92
SUPPORT24.48
SUPPORT24.05
SUPPORT23.34
 
RVMD Forecast May 2024
4th UP Forecast40.05
3rd UP Forecast35.4
2nd UP Forecast32.52
1st UP Forecast29.64
1st DOWN Forecast21.44
2nd DOWN Forecast18.56
3rd DOWN Forecast15.68
4th DOWN Forecast11.03
 
RVMD Weekly Forecast
4th UP Forecast31.32
3rd UP Forecast29.47
2nd UP Forecast28.32
1st UP Forecast27.18
1st DOWN Forecast23.91
2nd DOWN Forecast22.76
3rd DOWN Forecast21.61
4th DOWN Forecast19.76
 
RVMD Forecast2024
4th UP Forecast58.86
3rd UP Forecast48.17
2nd UP Forecast41.57
1st UP Forecast34.96
1st DOWN Forecast16.12
2nd DOWN Forecast9.51
3rd DOWN Forecast2.91
4th DOWN Forecast-7.78
 
 
RVMD Other Details
Segment EQ
Market Capital 2189034752.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RVMD Address
RVMD
 
RVMD Latest News
 
Your Comments and Response on Revolution Medicines Inc
 
RVMD Business Profile
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). Revolution Medicines, Inc. has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. The company was incorporated in 2014 and is headquartered in Redwood City, California. Address: 700 Saginaw Drive, Redwood City, CA, United States, 94063
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service